Polyphyletic screen defines distinct classes of plant-derived natural products that oppose tauopathy
Life Science Alliance · 2026
DOI: 10.26508/lsa.202503393 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2026. Verfasst von Chatrawee D Shepard und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Appalachian Natural Products Research Program, Department of Biomedical Sciences, The Joan C. Edwards School of Medicine, Marshall University, Hu…. Hauptthemen laut MEDLINE: Biological Products, Tauopathies. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a debilitating neurodegenerative disease hallmarked by the presence of amyloid-β (Aβ) plaques and tau fibrils but with limited treatment options. Here, we describe two plant-derived natural products with distinct mechanisms of action on tau fibril disaggregation and prionogenic seeding. We first characterized the effects of oolonghomobisflavan A (OFA) and oolonghomobisflavan B (OFB) treatments, which alter the transcriptional landscape toward enhanced proteostasis and reverse the shortened lifespan in a Caenorhabditis elegans model expressing pathogenic human tau (“hTau-expressing”), but increase healthspan. Mechanistically, OFA treatment reduced the burden of tau protein aggregation and promoted tau disaggregation in hTau-expressing C. elegans and also inhibited seeding in assays using ex vivo brain-derived paired helical filament tau protein fibrils from Alzheimer’s disease brain donors. We leveraged this finding to develop a facile screening approach for compounds, like OFA, that could mitigate tau aggregation, which revealed plumbagin (PB) as a potent inhibitor of tau monomer aggregation which is mechanistically distinct from the tau fibril disaggregase activity associated with OFA. Collectively, this study reveals a new strategy for identifying therapeutic compounds that target tauopathy and provides mechanistic insight supporting the neuroprotective effects of plant-derived natural products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Appalachian Natural Products Research Program, Department of Biomedical Sciences, The Joan C. Edwards School of Medicine, Marshall University, Huntington, WV, USA duangjan@marshall.edu.
- Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA, USA.
- Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, USA.
- Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA, USA spcurran@usc.edu.
ORCID-Profile: Chatrawee D Shepard, Sean P Curran
Förderung
- NIA NIH HHS
- NIH HHS
- National Institutes of Health
- Hevolution Foundation
- Nathan Shock Center of Excellence
- NIH Office of Research Infrastructure Programs
Zitieren
APA
Shepard, C. D., Chang, X., Seidler, P. M., & Curran, S. P. (2026). Polyphyletic screen defines distinct classes of plant-derived natural products that oppose tauopathy. Life Science Alliance. https://doi.org/10.26508/lsa.202503393
Vancouver
Shepard CD, Chang X, Seidler PM, Curran SP. Polyphyletic screen defines distinct classes of plant-derived natural products that oppose tauopathy. Life Science Alliance. 2026. doi:10.26508/lsa.202503393
BibTeX
@article{Shepard2026,
author = {Shepard, Chatrawee D and Chang, Xinmin and Seidler, Paul M and Curran, Sean P},
title = {Polyphyletic screen defines distinct classes of plant-derived natural products that oppose tauopathy},
journal = {Life Science Alliance},
year = {2026},
doi = {10.26508/lsa.202503393}
}
EUVIMED